🇺🇸 FDA
Pipeline program

Placebo to Descartes-08, Descartes-08

RNAC-MG-002 (AURORA)

Phase 3 small_molecule active

Quick answer

Placebo to Descartes-08, Descartes-08 for generalized myasthenia gravis is a Phase 3 program (small_molecule) at Cartesian Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Cartesian Therapeutics
Indication
generalized myasthenia gravis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials